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ABSTRACT
Background: Elevated homocysteine concentrations are associated
with an increased risk of cardiovascular disease and a decline in
cognitive function. Intakes of choline and betaine, as methyl donors,
may affect homocysteine concentrations.
Objective: The objective was to examine whether choline and be-
taine intakes, assessed from food-frequency questionnaires, are as-
sociated with total plasma homocysteine concentrations under both
fasting and post–methionine-load conditions in both pre– and post–
folic acid fortification periods in the United States.
Design: We assessed the association between choline and betaine
intakes and fasting and post–methionine-load homocysteine con-
centrations using the US Department of Agriculture revised food-
composition tables and evaluated whether the associations varied by
folic acid fortification periods in 1325 male and 1407 female par-
ticipants in the sixth examination (1995–1998) of the Framingham
Offspring Study.
Results: A higher choline-plus-betaine intake was associated with
lower concentrations of post–methionine-load homocysteine; the
multivariate geometric means were 24.1 lmol/L (95% CI: 23.4,
24.9 lmol/L) in the top quintile of intake and 25.0 lmol/L (95%
CI: 24.2, 25.7 lmol/L) in the bottom quintile (P for trend = 0.01).
We found an inverse association between choline-plus-betaine in-
take and fasting homocysteine concentrations; the multivariate geo-
metric mean fasting homocysteine concentrations were 9.6 lmol/L
(95% CI: 9.3, 9.9 lmol/L) in the top quintile and 10.1 lmol/L (95%
CI: 9.8, 10.4 lmol/L) in the bottom quintile (P for trend , 0.001).
When we stratified by plasma folate and vitamin B-12 concentra-
tions, the inverse association was limited to participants with low
plasma folate or vitamin B-12 concentrations. In the postfortifica-
tion period, the inverse association between choline-plus-betaine
intake and either fasting or post–methionine-load homocysteine
was no longer present.
Conclusions: Choline and betaine intakes were associated with
both fasting and post–methionine-load total homocysteine concen-
trations, especially in participants with low folate and vitamin B-12
status. The inverse association between choline and betaine intakes
and homocysteine concentrations was no longer present in the post-
fortification period. Am J Clin Nutr 2010;91:1303–10.
INTRODUCTION
Choline is important for the structural integrity of cell mem-
branes, methyl metabolism, cholinergic neurotransmission, trans-
membrane signaling, and lipid and cholesterol transport and
metabolism, because it is a precursor for acetylcholine, phos-
pholipids, and the methyl donor betaine (1). Like 5-methylte-
trahydrofolate, once choline is oxidized to betaine, it can provide
the necessary one-carbon unit in the conversion of homocysteine to
methionine, thus generating S-adenosylmethionine (SAM)—the
universal methyl donor (1). These folate and choline metabolic
pathways are closely interrelated (2, 3). It has been estimated
that ’60% of methyl groups are derived from choline, 20%
from methionine, and 10–20% from folate (3), which supports
the central role of choline as a methyl donor.
Elevated homocysteine concentrations have been associated
with low concentrations of B vitamins involved in one-carbon
metabolism, including folate, vitamin B-12, and vitamin B-6 (3–
6). Elevated homocysteine concentrations in individuals with
B vitamin deficiency may indicate a disturbance in one-carbon
metabolism (3, 7, 8). In addition to fasting homocysteine con-
centrations, the effect of an oral methionine load on homo-
cysteine concentrations can be used to test the capacity of the
homocysteine removal pathways; an abnormal rise in homo-
cysteine concentrations after a methionine load indicates in-
adequate capacity for methylation or transsulfuration of the
excess homocysteine generated from methionine (7, 9). Post–
methionine-load homocysteine concentrations may be more
sensitive than fasting concentrations as a marker of hyper-
homocysteinemia (10). High concentrations of homocysteine are
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associated with an elevated risk of stroke (11, 12), coronary heart
disease (13), and cognitive decline (14–16).
Because of the role of choline and betaine as methyl donors
in the one-carbon metabolism, epidemiologic studies evaluating
dietary choline and betaine intakes in relation to risk of several
chronic diseases (17–23) found an elevated risk of colorectal
adenoma (17) and prostate cancer (23) and lower concentrations
of inflammation markers (22) with higher choline intakes, an
inverse association between choline intake and breast cancer
(20), and no association between choline or betaine intake and
premenopausal breast cancer (19) and cardiovascular disease
(18, 21).
We previously found that choline and betaine intakes predicted
fasting homocysteine concentrations, which supports the bi-
ological role of choline and betaine in one-carbon metabolism.
However, neither our previous study (24) nor those by other
researchers (18, 25–29) evaluated the association between cho-
line and betaine and homocysteine concentrations in populations
receiving folic acid fortification, which is more relevant to cur-
rent situations in the United States and some other countries.
Therefore, in our current study, using blood samples from the
sixth examination of the Framingham Offspring Study cohort, we
examined the association between choline and betaine intakes
and fasting and post–methionine-load homocysteine concen-
trations and sought to determine whether the associations were
affected by folic acid fortification.
SUBJECTS AND METHODS
Study populations
The Framingham Offspring Study consisted of offspring and
their spouses of the participants of the Framingham Heart Study,
which was established in Framingham, MA, between 1948 and
1950 with a cohort of 5209 men and women aged 30–59 y. By
1971, the original cohort included 1644 husband-wife pairs and
1921 individuals without a spouse in the cohort. The offspring of
the original cohort and the offsprings’ spouses were invited to
participate in the Framingham Offspring Study, and 5315 of the
6838 eligible individuals participated in the first examination in
1971–1974 (30). The offspring cohort has subsequently un-
dergone follow-up examinations approximately every 3–4 y. The
sixth offspring cohort examination began in January 1995 and
was completed in August 1998. In March of 1996, the US Food
and Drug Administration mandated that all enriched flour and
uncooked cereal grains be fortified with 140 lg folic acid/100 g
flour per grain by January 1998. In New England, most of the
targeted products were fortified with folic acid by July 1997
(31). Therefore, the sixth examination covered both the pre- and
postfortification periods of folic acid. We excluded participants
who did not have valid food-frequency questionnaires (FFQs),
did not have data on either fasting homocysteine or post–
methionine-load homocysteine, had a diagnosis of cardiovas-
cular disease, or were taking medications that might alter
homocysteine concentrations (32). A total of 1325 men and
1407 women aged 29–86 y were included in the current anal-
yses. The procedures and protocols of the study were approved
by the Institutional Review Board for Human Research at
Boston Medical Center.
Measurements
Dietary information was collected from the participants by
using validated FFQs that included’130 food items (33). Before
the sixth examination, the FFQs were mailed to the participants,
who were asked to complete the form and bring it to their ap-
pointment. The participants were asked how frequently, on av-
erage, during the past year they consumed one standard serving
of a specific food item in 9 categories (,1/mo, 1–3/mo, 1/wk,
2–4/wk, 5–6/wk, 1/d, 2–3/d, 4–5/d, or 6 /d). Responses on
frequencies of a specified serving size for each food item were
converted to average daily intake. An individual’s intakes of
choline, betaine, and B vitamins from foods were calculated by
multiplying the reported intake frequency of each food by the
nutrient content of one serving of that food (34–36). The choline
and betaine composition of individual foods was added to
the FFQ’s nutrient database (Harvard University Food Compo-
sition Database) with the use of values published by Zeisel et al
(34) and from the recent US Department of Agriculture’s cho-
line database with updated betaine values (35). We used the
regression-residual method to adjust nutrient intakes for a total
energy intake of 1777.5 kcal/d (median energy intake in this
population) (37). We took into account the participants’ current
use of B vitamin supplements and the type of breakfast cereal
they consumed to calculate vitamin B intake. For participants
who provided FFQs after folic acid fortification was fully im-
plemented (September 1997 to August 1998) (31), folic acid
from fortified foods was included in their total folate intake.
Blood samples were obtained during the sixth examinations
from participants who had fasted for .10 h to determine the
concentrations of homocysteine, folate, vitamin B-12, and pyr-
idoxal 5#-phosphate (PLP)—an active form of vitamin B-6.
After the fasting phlebotomy, methionine (100 mg/kg) was
immediately administered in 200 mL fruit juice. Two hours
later, repeat plasma samples were obtained for homocysteine
measurement. Both homocysteine concentrations were mea-
sured by HPLC with fluorescence detection (38). Plasma folate
was measured with a microbial (Lactobacillus casei) assay in
a 96-well plate (39). Plasma PLP was measured with an enzy-
matic procedure using radioactive tyrosine and the apo-enzyme
tyrosine decarboxylase (40). Plasma vitamin B-12 was measured
with a commercially available radioimmunoassay kit (Quanta-
phase II; Bio-Rad, Hercules, CA). All assays were conducted at
the laboratory of Jacob Selhub at the Jean Mayer US De-
partment of Agriculture Human Nutrition Research Center on
Aging at Tufts University. The mean intraassay CVs were 8%
for homocysteine, 13% for plasma folate, 16% for PLP, and 7%
for plasma vitamin B-12. Laboratory personnel were blinded to
the quality-control status and the participants’ choline and be-
taine intakes.
Statistical analyses
We examined the correlations between intakes of betaine, total
choline, individual choline compounds, folate, and vitamins B-6
and B-12 and homocysteine concentrations using Spearman
correlations. Geometric mean and 95% CIs of plasma homo-
cysteine concentrations were calculated based on exponentiation
of log-transformed values according to quintiles of choline and
betaine intakes. To test for trend across quintiles, participants
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were assigned the median value of their quintile level. This
variable was entered as a continuous term, the coefficient for
which was evaluated by the Wald test. In the multivariate
analyses, we adjusted for age, sex, smoking (none or currently
1–15, 16–25, or 26 cigarettes/d), total energy intake (contin-
uous), alcohol intake (continuous), serum creatinine concen-
trations (continuous), and intakes of folate (continuous), vitamin
B-6 (continuous), and vitamin B-12 (continuous), which may
influence homocysteine concentrations. We examined whether
the associations between choline-plus-betaine intake and ho-
mocysteine concentrations differed by periods based on folic
acid fortification (prefortification period: January 1995 to Sep-
tember 1996; transition period: October 1996 to August 1997;
and postfortification period: September 1997 to August 1998)
(31), folate intake, alcohol intake, age, sex, and concentrations
of plasma folate, PLP, and vitamin B-12 by introducing a cross-
product term (choline-plus-betaine · the factor of interest) in the
multivariate model. P , 0.05 (2 sided) was considered signifi-
cant. All statistical analyses were performed by using SAS 9.1
(SAS Institute, Cary, NC) (41).
RESULTS
The energy-adjusted means (6SDs) were 437 6 78 mg/d for
choline-plus-betaine, 308 6 56 mg/d for choline intake, and
129 6 49 mg/d for betaine intake (Table 1). Post–methionine-
load homocysteine concentrations were 2.5-fold higher than
fasting concentrations; the means (6 SDs) were 25 6 8 and 10 6
4 lmol/L, respectively (P , 0.001). Choline and betaine intakes
were weakly correlated (r = 0.15, P , 0.001). For choline from
individual sources, choline from phosphatidylcholine and choline
from sphingomyelin were highly correlated. The correlation co-
efficients between total choline or betaine intake and dietary one-
carbon nutrients ranged from 0.09 to 0.28 (P , 0.001).
Higher choline-plus-betaine intake was associated with lower
fasting homocysteine concentrations, as in our previous study
(24) (Table 2); the geometric means of fasting homocysteine
concentrations were 10.1 (95% CI: 9.8, 10.4) lmol/L in the
bottom quintile of choline-plus-betaine intake and 9.6 (95% CI:
9.3, 9.9) lmol/L in the top quintile (P for trend , 0.001).
Choline and betaine intakes were each inversely associated with
fasting homocysteine concentrations. Of choline from different
sources, choline from glycerophosphocholine, choline from phos-
phocholine, and choline from sphingomyelin were each inversely
associated with fasting homocysteine concentrations (data not
shown).
Like with fasting homocysteine, we also observed a statisti-
cally significant inverse association between choline-plus-betaine
intake and post–methionine-load homocysteine concentrations
(Table 2). The results with adjustment for intake of folate, vitamin
B-6, and vitamin B-12 (Table 2) were similar to those without
adjustment for intakes of these other one-carbon nutrients (data
not shown). The geometric means of post–methionine-load
homocysteine concentrations were 25.0 (95% CI: 24.2, 25.7)
lmol/L in the bottom quintile and 24.1 (95% CI: 23.4, 24.9)
lmol/L in the top quintile (P for trend = 0.01). Higher betaine
intake was also significantly associated with lower post–
methionine-load homocysteine concentrations. However, the
association between choline intake and post–methionine-load
homocysteine concentrations was not statistically significant
(P for trend = 0.11). When we examined choline from different
sources, only choline intake from glycerophosphocholine
(major food sources: milk, fish, beer, coffee, and yogurt) was
significantly inversely associated with post–methionine-load
homocysteine concentrations (data not shown).
We examined whether the associations between choline-plus-
betaine intake and fasting and post–methionine-load homocysteine
concentrations differed according to folic acid fortification
(prefortification period, transition period, and postfortification
period), folate intake (,250, 250-,400, 400-,600, 600 mcg/
d), alcohol intake (none, 0.1 to ,15, 15 to ,30, and 30 g/d),
age (50, 51–60, 61–65, and .65 y), sex (men, women),
plasma folate (tertiles), plasma PLP (tertiles), and plasma vita-
min B-12 (tertiles) (Table 3). We found a significant inverse
association between choline-plus-betaine intake and fasting or
post–methionine-load homocysteine concentrations in the pre-
fortification period (P for trend , 0.05). The association be-
tween choline-plus-betaine intake and fasting homocysteine
concentrations was more pronounced in participants whose
plasma concentrations of folate or vitamin B-12 were low (P for
interaction = 0.05 for plasma folate and 0.02 for plasma vitamin
B-12). When we limited participants to those with low plasma
folate (bottom tertile), low plasma vitamin B-12 (bottom tertile),
and alcohol intake .15 g/d (n = 121), the geometric means
(95% CI) of fasting homocysteine concentrations were 14.4
(95% CI: 12.1, 17.3) lmol/L in the bottom quintile and 12.8
(95% CI: 10.5, 15.6) lmol/L in the top quintile (P for trend =
0.12). Likewise, the inverse association between choline-
plus-betaine intake and post–methionine-load homocysteine
concentrations was limited to the prefortification period (P for
interaction = 0.06) or those with low plasma vitamin B-12
concentrations (P for interaction = 0.06). The association between
choline-plus-betaine intake and fasting or post–methionine-load
homocysteine concentrations was more pronounced in men than
in women (P for interaction = 0.05 for fasting and 0.09 for post–
methionine-load homocysteine).
We further examined whether the associations between cho-
line-plus-betaine intake and fasting and post–methionine-load
homocysteine concentrations varied by factors related to one-
carbon pathways in the post–folic acid fortification period. We
found that the associations did not vary by plasma concentrations
of PLP or vitamin B-12 (P for interaction  0.15).
DISCUSSION
We found an inverse association between choline and betaine
intakes and either fasting or post–methionine-load homocysteine
concentrations in the prefolic acid fortification period, but not
after fortification. We also observed that inverse associations be-
tween choline-plus-betaine intake and fasting or post–methionine-
load homocysteine concentrations were limited to participants
whose folate and vitamin B-12 statuswas low. Our findings suggest
that high folate levels attenuated the association between choline-
plus-betaine and homocysteine concentrations.
In our previous study (24), choline and betaine intakes showed
an inverse relation to fasting total plasma homocysteine con-
centrations, particularly in participants with low folate intakes or
who consumed alcohol, using blood samples from the fifth ex-
amination (January 1991 to December 1994) of the study cohort.
Inverse associations in that study (24), which was conducted
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before the implementation of mandatory folic acid fortification of
grain products, were generally stronger that those in the present
study, which covers both pre- and postfortification periods.
Another study of 1477 women in the Nurses’ Health Study found
an inverse association between choline-plus-betaine intake and
fasting homocysteine concentrations (29), and a Dutch study
including 903 women found no association for betaine intake, but
a weak inverse association between choline intake and homo-
cysteine concentrations in blood samples collected after a fast of
2-h (18). None of these studies evaluated choline intake in
relation to post–methionine-load homocysteine concentrations
or during the post–folic acid fortification period.
Our data support the contention that individuals with low folate
and vitamin B-12 status may benefit from intake of choline and
betaine. This concurs with animal studies indicating that folate
and choline metabolism intersect at the remethylation of
homocysteine to form methionine in one-carbon pathways (2).
Studies report a reduction in hepatic choline content in rats fed
a folate-deficient diet compared with controls (42). Similarly,
total hepatic folate content (43, 44) or hepatic SAM content (45)
decreased in rats fed a choline-deficient diet compared with
controls. Methylenetetrahydrofolate reductase or cystathionine-
b-synthase knockout mice, which accumulate homocysteine,
have depleted choline and betaine pools in the liver (46, 47).
Methionine adenosyltransferase knockout mice, which have
impaired formation of SAM and activated gene expression of
betaine-homocysteine methyltransferase, also have increased
dietary choline requirements (48).
Elevated concentrations of homocysteine may be a marker of
diminished capacity of the remethylation or transsulfuration
pathways (7). Although some randomized controlled trials re-
ported no effect of B vitamin supplementation associated with
reduction in homocysteine concentrations on myocardial in-
farction (12, 49), or deaths from cardiovascular disease (12) in
patients with existing cardiovascular diseases, a meta-analysis of
prospective studies that included only participants who did not
have preexisting cardiovascular diseases showed an 18% in-
creased risk of coronary events associated with a 5-lmol/L
increment of homocysteine concentrations (13). Another meta-
analysis (11) found an 11% lower risk of ischemic heart disease
and a 19% lower risk of stroke associated with 25% lower ho-
mocysteine concentrations.
Several crossover studies or randomized trials have shown that
a diet deficient in choline increased fasting homocysteine con-
centrations (50) and that supplementation with choline or betaine
either decreased fasting homocysteine concentrations (26, 27) or
attenuated the rise in post–methionine-load homocysteine con-
centrations (25–27). Our study of .2700 free-living healthy
participants provides further evidence that the range of choline
and betaine intakes from foods still predicts both fasting and
post–methionine-load homocysteine concentrations, especially
given low folate and vitamin B-12 status.
Of the individual sources of choline, the esters glycer-
ophosphocholine, phosphocholine, and sphingomyelin were as-
sociated with fasting homocysteine concentrations, but only
glycerophosphocholine was statistically significantly associated
with post–methionine-load homocysteine concentrations. Our
previous study using the 5th examination of the Framingham
Offspring Study found significant inverse associations for free
choline, glycerophosphocholine, phosphocholine, and sphingo-
myelin (24). The study in the Nurses’ Health Study also found
a significant inverse association for glycerophosphocholine and
phosphocholine in relation to fasting homocysteine concentrations
(29). The consistent inverse association for glycerophosphocho-
line found in these 3 studies merits further examination, given that
the differences in the metabolism and specific roles of individual
choline compounds remain unknown.
We found a stronger association in men than in women,
consistent with our previous study (24). It is possible that women
are less reliant on dietary sources of choline because of an en-
hanced capacity for endogenous synthesis of choline due to
estrogen-induction of the gene for this pathway (51, 52).
TABLE 2
Multivariate-adjusted geometric mean (95% CI) fasting and post–methionine-load homocysteine concentrations (lmol/L) by quintile of energy-adjusted
choline and betaine intakes in 1325 male and 1407 female participants in the Framingham Offspring Study: 1995–19981
Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 P for trend2
Fasting homocysteine
Choline + betaine (mg/d)
Median 6 SD 344 6 34 395 6 12 433 6 11 473 6 13 550 6 52
Geometric mean (95% CI) 10.1 (9.8, 10.4) 10.0 (9.7, 10.3) 9.7 (9.5, 10.0) 9.7 (9.4, 10.0) 9.6 (9.3, 9.9) ,0.001
Choline (mg/d)
Median 6 SD 234 6 25 278 6 9 305 6 7 334 6 10 379 6 36
Geometric mean (95% CI) 10.1 (9.8, 10.4) 10.1 (9.8, 10.4) 9.7 (9.5, 10.0) 9.7 (9.4, 9.9) 9.7 (9.4, 9.9) 0.001
Betaine (mg/d)
Median 6 SD 77 6 12 102 6 5 120 6 5 143 6 8 203 6 50
Geometric mean (95% CI) 10.1 (9.8, 10.4) 9.9 (9.6, 10.2) 9.7 (9.4, 10.0) 9.8 (9.5, 10.1) 9.6 (9.3, 9.9) ,0.001
Post–methionine-load homocysteine
Choline + betaine
Geometric mean (95% CI) 25.0 (24.2, 25.7) 25.0 (24.2, 25.8) 24.3 (23.6, 25.1) 24.2 (23.5, 25.0) 24.1 (23.4, 24.9) 0.01
Choline
Geometric mean (95% CI) 24.5 (23.8, 25.3) 25.6 (24.8, 26.4) 24.0 (23.3, 24.8) 24.4 (23.7, 25.2) 24.3 (23.6, 25.0) 0.11
Betaine
Geometric mean (95% CI) 24.9 (24.1, 25.7) 24.8 (24.1, 25.6) 24.3 (23.6, 25.1) 24.6 (23.9, 25.4) 24.0 (23.2, 24.8) 0.04
1 Values were adjusted for age, sex, smoking, alcohol intake, total energy intake, serum creatinine concentration, and intakes of folate, vitamin B-6, and
vitamin B-12.
2 P for trend (2-sided) was calculated by using the Wald test statistic.
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TABLE 3
Multivariate-adjusted geometric mean (95% CI) fasting and post–methionine-load homocysteine concentrations (lmol/L) by quintile of energy-adjusted
choline-plus-betaine intake and categories of other factors in 1325 male and 1407 female participants in the Framingham Offspring Study, 1995–19981




Folic acid fortification status3 0.95
Prefortification (n = 1252) 10.5 (10.0, 11.0) 10.0 (9.5, 10.4) 10.0 (9.6, 10.5) 10.2 (9.7, 10.6) 9.8 (9.4, 10.3)
Transition period (n = 785) 10.1 (9.6, 10.6) 10.2 (9.7, 10.8) 9.7 (9.2, 10.2) 9.2 (8.8, 9.7) 9.5 (9.0, 10.0)
Postfortification (n = 695) 9.6 (9.1, 10.2) 9.9 (9.4, 10.4) 9.6 (9.1, 10.1) 9.6 (9.1, 10.1) 9.3 (8.8, 9.8)
Folate intake 0.44
,250 lg/d (n = 284) 11.8 (11.0, 12.7) 11.1 (10.2, 12.0) 10.7 (9.8, 11.7) 10.8 (9.6, 12.3) 11.7 (10.3, 13.3)
250 to ,400 lg/d (n = 770) 10.8 (10.2, 11.4) 10.7 (10.2, 11.3) 11.0 (10.4, 11.6) 11.0 (10.4, 11.6) 10.3 (9.7, 11.0)
400 to ,600 lg/d (n = 680) 9.5 (8.9, 10.1) 9.4 (8.9, 10.0) 9.4 (8.9, 9.9) 9.1 (8.6, 9.7) 9.3 (8.8, 9.9)
600 lg/d (n = 998) 8.7 (8.3, 9.2) 9.1 (8.6, 9.5) 8.6 (8.1, 9.0) 8.5 (8.1, 9.0) 8.5 (8.1, 8.9)
Alcohol intake 0.21
0 g/d (n = 718) 9.7 (9.2, 10.2) 9.4 (8.9, 9.9) 9.7 (9.1, 10.3) 9.6 (9.0, 10.2) 9.5 (8.9, 10.0)
.0 to ,15 g/d (n = 1401) 9.9 (9.5, 10.3) 10.0 (9.6, 10.5) 9.6 (9.2, 10.0) 9.4 (9.0, 9.8) 9.4 (9.0, 9.8)
15 to ,30 g/d (n = 247) 11.2 (9.9, 12.7) 10.9 (9.7, 12.3) 9.8 (8.8, 11.0) 10.2 (9.1, 11.5) 9.8 (8.7, 11.0)
30 g/d (n = 366) 11.5 (10.6, 12.5) 10.7 (9.9, 11.5) 10.3 (9.4, 11.2) 10.9 (10.1, 11.8) 10.4 (9.7, 11.1)
Age 0.79
50 y (n = 602) 9.9 (9.3, 10.4) 9.1 (8.6, 9.7) 9.2 (8.7, 9.8) 8.9 (8.4, 9.5) 9.2 (8.7, 9.8)
51 to 60 y (n = 978) 9.5 (9.1, 10.0) 9.8 (9.4, 10.3) 9.2 (8.8, 9.6) 9.5 (9.0, 9.9) 9.1 (8.7, 9.5)
61 to 65 y (n = 448) 10.3 (9.6, 11.2) 10.0 (9.3, 10.8) 9.8 (9.0, 10.6) 9.7 (9.0, 10.5) 9.4 (8.7, 10.2)
. 65 y (n = 704) 10.8 (10.1, 11.5) 10.9 (10.2, 11.6) 10.9 (10.1, 11.7) 10.5 (9.8, 11.3) 10.5 (9.8, 11.2)
Sex 0.05
Male (n = 1325) 11.0 (10.5, 11.4) 10.8 (10.4, 11.3) 10.5 (10.1, 10.9) 10.4 (10.0, 10.8) 10.1 (9.7, 10.5)4
Female (n = 1407) 9.3 (8.9, 9.7) 9.2 (8.8, 9.6) 9.0 (8.6, 9.4) 9.0 (8.6, 9.4) 9.0 (8.6, 9.4)
Plasma folate 0.05
,6 ng/mL (n = 908) 12.0 (11.4, 12.6) 11.5 (11.0, 12.1) 11.8 (11.2, 12.4) 11.3 (10.8, 11.9) 11.1 (10.5, 11.7)4
6 to ,12 ng/mL (n = 916) 9.6 (9.2, 10.0) 9.7 (9.3, 10.1) 9.3 (8.9, 9.6) 9.2 (8.8, 9.6) 9.3 (9.0, 9.8)
12 ng/mL (n = 908) 8.6 (8.1, 9.1) 8.5 (8.0, 9.0) 8.3 (7.8, 8.8) 8.4 (7.9, 8.9) 8.2 (7.8, 8.7)
Plasma PLP 0.32
,48 nmol/L (n = 911) 10.9 (10.4, 11.5) 10.8 (10.3, 11.3) 10.9 (10.4, 11.5) 10.3 (9.8, 10.9) 10.7 (10.1, 11.3)
48 to ,80 nmol/L (n = 910) 10.0 (9.5, 10.5) 9.9 (9.4, 10.4) 9.6 (9.2, 10.1) 9.7 (9.3, 10.3) 9.6 (9.1, 10.1)
80 nmol/L (n = 911) 8.9 (8.4, 9.4) 8.7 (8.3, 9.2) 8.3 (7.8, 8.8) 8.6 (8.1, 9.0) 8.2 (7.8, 8.6)
Plasma vitamin B-12 0.02
,334 pg/mL (n = 910) 11.5 (10.9, 12.1) 11.4 (10.8, 12.0) 10.9 (10.3, 11.5) 10.7 (10.2, 11.3) 10.4 (9.8, 11.0)4
334 to ,459 pg/mL (n = 911) 9.9 (9.4, 10.3) 9.8 (9.3, 10.2) 10.0 (9.5, 10.4) 9.7 (9.2, 10.1) 9.9 (9.5, 10.4)
459 pg/mL (n = 911) 9.0 (8.5, 9.5) 9.0 (8.5, 9.4) 8.5 (8.1, 9.0) 8.8 (8.3, 9.2) 8.6 (8.2, 9.0)
Post–methionine-load homocysteine
Folic acid fortification status3 0.06
Prefortification (n = 1252) 25.7 (24.6, 26.9) 24.8 (23.6, 25.9) 24.9 (23.7, 26.1) 24.6 (23.5, 25.7) 24.1 (23.1, 25.3)
Transition period (n = 785) 25.1 (23.8, 26.6) 26.8 (25.3, 28.4) 25.0 (23.6, 26.5) 23.7 (22.3, 25.1) 24.7 (23.3, 26.2)
Postfortification (n = 695) 23.5 (22.1, 25.0) 23.7 (22.4, 25.1) 23.0 (21.7, 24.5) 24.2 (22.8, 25.6) 23.2 (21.8, 24.7)
Folate intake 0.26
,250 lg/d (n = 284) 28.4 (26.6, 30.3) 26.1 (24.2, 28.2) 26.5 (24.3, 28.8) 25.3 (22.5, 28.4) 27.7 (24.6, 31.2)
250 to ,400 lg/d (n = 770) 26.1 (24.7, 27.7) 27.1 (25.6, 28.6) 27.2 (25.7, 28.8) 26.8 (25.3, 28.3) 25.5 (23.9, 27.2)
400 to ,600 lg/d (n = 680) 23.5 (22.0, 25.2) 23.4 (21.9, 25.0) 23.3 (21.9, 24.8) 23.0 (21.6, 24.6) 23.4 (21.9, 25.0)
600 lg/d (n = 998) 22.6 (21.3, 23.9) 23.6 (22.3, 24.9) 22.0 (20.8, 23.4) 22.2 (21.0, 23.4) 22.4 (21.3, 23.6)
Alcohol intake 0.82
0 g/d (n = 718) 23.3 (22.0, 24.5) 22.8 (21.6, 24.2) 22.7 (21.3, 24.2) 22.6 (21.3, 24.1) 23.0 (21.6, 24.4)
.0 to ,15 g/d (n = 1401) 24.6 (23.5, 25.7) 25.2 (24.1, 26.4) 24.4 (23.3, 25.5) 23.8 (22.8, 24.8) 23.7 (22.6, 24.8)
15 to ,30 g/d (n = 247) 29.3 (26.0, 32.9) 27.7 (24.8, 31.0) 26.5 (23.8, 29.4) 28.3 (25.3, 31.7) 27.4 (24.4, 30.7)
30 g/d (n = 366) 29.4 (26.9, 32.0) 28.0 (25.8, 30.3) 26.7 (24.4, 29.2) 27.6 (25.5, 30.0) 27.5 (25.6, 29.5)
Age 0.38
50 y (n = 602) 24.8 (23.4, 26.4) 23.5 (22.1, 25.0) 24.4 (23.0, 25.9) 23.5 (22.0, 25.0) 24.3 (22.8, 25.9)
51 to 60 y (n = 978) 24.0 (22.8, 25.2) 25.0 (23.7, 26.2) 24.1 (22.9, 25.3) 24.2 (23.0, 25.4) 24.0 (22.8, 25.3)
61 to 65 y (n = 448) 26.0 (23.9, 28.3) 26.1 (24.0, 28.3) 24.2 (22.2, 26.5) 24.2 (22.3, 26.4) 23.1 (21.2, 25.1)
.65 y (n = 704) 25.5 (23.9, 27.2) 25.7 (24.1, 27.5) 24.6 (22.9, 26.3) 24.8 (23.2, 26.6) 24.7 (23.1, 26.4)
Sex 0.09
Male (n = 1325) 24.3 (23.3, 25.3) 24.2 (23.2, 25.2) 23.4 (22.4, 24.4) 23.5 (22.6, 24.5) 23.2 (22.3, 24.1)
Female (n = 1407) 25.2 (24.0, 26.4) 25.6 (24.4, 26.8) 25.0 (23.9, 26.2) 24.7 (23.5, 25.9) 24.9 (23.8, 26.2)
(Continued)
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Our study had several limitations. Because the assessment of
choline and betaine intakes through FFQs and blood collection
were made within a short period of time, our study may not fully
reflect the temporal relation between choline and betaine intakes
and homocysteine concentrations. However, because the FFQs
we used were designed to assess long-term dietary intake (53),
choline and betaine intakes in our study might reflect choline and
betaine intakes before homocysteine measurement.
The strengths of our study include a large sample size and
measurements of both fasting and post–methionine-load homo-
cysteine concentrations as well as circulating concentrations of
folate, vitamin B-6, and vitamin B-12. Inclusion of .2700
participants gave us considerable statistical power to evaluate
whether the associations varied according to several factors re-
lated to the one-carbon pathway, including vitamin B status and
alcohol intake. Plasma concentrations of folate and vitamins B-6
and B-12 may reflect the bioavailability of these B vitamins,
including malabsorption and intakes from fortified foods, un-
fortified foods, and supplements. Because some participants’
blood samples were collected after folic acid fortification began
(n = 695), we were able to examine the association between
choline and betaine intakes and homocysteine concentrations
during the folic acid fortification era, which could be applied to
the current US general population.
In conclusion, choline and betaine intakes were associated
with both fasting and post–methionine-load total homocysteine
concentrations, especially in participants with low folate and
vitamin B-12 status. Choline and betaine intakes were associated
with both fasting and post–methionine-load homocysteine con-
centrations in the prefolic acid fortification period, but the as-
sociation was no longer present in the postfortification period.
Intake of choline and betaine may still be important in pop-
ulations who do not receive folic acid fortification and for
individuals with low folate or vitamin B-12 status.
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